Hongjing Jiang

Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Hao Wang, Han Tang, Yong Fang et al. · JAMA Surgery · 2021 · 179 citations · Full text

The predictive value of a preoperative systemic immune‐inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma

Hongdian Zhang, Xiaobin Shang, Peng Ren et al. · Journal of Cellular Physiology · 2018 · 154 citations

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 144 citations · Full text

Surgical Oncology, Esophageal Cancer, Neoadjuvant Therapy +16

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study

Wencheng Zhang, Cihui Yan, Tian Zhang et al. · OncoImmunology · 2021 · 98 citations · Full text

Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)

Xiaobin Shang, Gang Zhao, Fei Liang et al. · Annals of Translational Medicine · 2022 · 59 citations · Full text